WebGlobeNewswire. Alimera Sciences, Inc., a pharmaceutical company, engages in the development and commercialization of ophthalmic pharmaceuticals. It operates through United States, internationally, and Operating Cost segments. It offers ILUVIEN, an intravitreal implant for the treatment of diabetic macular edema (DME), which is a … WebApr 6, 2024 · ALIMERA SCIENCES, INC. : Shareholders Board Members Managers and Company Profile US0162592028 MarketScreener Homepage Equities United States Nasdaq Alimera Sciences, Inc. Company ALIM US0162592028 ALIMERA SCIENCES, INC. (ALIM) Add to my list Report Summary Quotes Charts News Ratings Calendar …
Should You Add Alimera Sciences Inc (ALIM) Stock to Your …
WebMar 17, 2024 · Alimera Sciences, Inc. Common Stock (ALIM) Stock Price, Quote, News & History Nasdaq Alimera Sciences, Inc. Common Stock (ALIM) Add to Watchlist Add to Portfolio Quotes Summary... WebApr 9, 2024 · ALIM Stock Overview Alimera Sciences, Inc., a pharmaceutical company, engages in the development and commercialization of ophthalmic pharmaceuticals in the United States and internationally. About the company Rewards Revenue is forecast to grow 13.07% per year Risk Analysis Has less than 1 year of cash runway Negative … sum or difference of logarithms calculator
Alimera Sciences NasdaqGM:ALIM Stock Report - Simply Wall St
WebMar 27, 2024 · -Alimera Sciences Inc ( ALIM) stock is trading at $1.76, an increase of $0.41, or 30.24%, on high volume. Alimera Sciences Inc gets a Sentiment Score of Very Bearish from InvestorsObserver and receives an average analyst recommendation of Strong Buy with a price target of $6.75. Alimera Sciences Inc next reports earnings on March 30. WebMar 31, 2024 · Alimera also repurchased 200,919 shares of common stock held by the Series A Preferred stockholders for approximately $314,000 Completed a $12 million private placement of Series B Preferred Stock and common stock warrants pursuant to a securities purchase agreement with Velan Capital and Caligan Partners. sumo salad harbour town